GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Clinical Diabetes and Healthcare |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcdhc.2024.1530811/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841553907820527616 |
|---|---|
| author | Ioannis Ilias Lina Zabuliene Manfredi Rizzo |
| author_facet | Ioannis Ilias Lina Zabuliene Manfredi Rizzo |
| author_sort | Ioannis Ilias |
| collection | DOAJ |
| format | Article |
| id | doaj-art-9d91925f546b47cda4eba38b24e041cf |
| institution | Kabale University |
| issn | 2673-6616 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Clinical Diabetes and Healthcare |
| spelling | doaj-art-9d91925f546b47cda4eba38b24e041cf2025-01-09T06:11:05ZengFrontiers Media S.A.Frontiers in Clinical Diabetes and Healthcare2673-66162025-01-01510.3389/fcdhc.2024.15308111530811GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risksIoannis Ilias0Lina Zabuliene1Manfredi Rizzo2Department of Endocrinology, Hippokration General Hospital, Athens, GreeceInstitute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, LithuaniaSchool of Medicine, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, Italyhttps://www.frontiersin.org/articles/10.3389/fcdhc.2024.1530811/fullglucagon-like peptide-1 receptor agonistsobesityweight lossdiabetesadverse drug reactionpancreatitis |
| spellingShingle | Ioannis Ilias Lina Zabuliene Manfredi Rizzo GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks Frontiers in Clinical Diabetes and Healthcare glucagon-like peptide-1 receptor agonists obesity weight loss diabetes adverse drug reaction pancreatitis |
| title | GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks |
| title_full | GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks |
| title_fullStr | GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks |
| title_full_unstemmed | GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks |
| title_short | GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks |
| title_sort | glp 1 receptor agonists in diabetes and weight loss the double edged sword of innovation and risks |
| topic | glucagon-like peptide-1 receptor agonists obesity weight loss diabetes adverse drug reaction pancreatitis |
| url | https://www.frontiersin.org/articles/10.3389/fcdhc.2024.1530811/full |
| work_keys_str_mv | AT ioannisilias glp1receptoragonistsindiabetesandweightlossthedoubleedgedswordofinnovationandrisks AT linazabuliene glp1receptoragonistsindiabetesandweightlossthedoubleedgedswordofinnovationandrisks AT manfredirizzo glp1receptoragonistsindiabetesandweightlossthedoubleedgedswordofinnovationandrisks |